The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study
DOI:
https://doi.org/10.2340/actadv.v104.40112Keywords:
Basal cell carcinoma, Skin cancer, EpidemiologyAbstract
Basal cell carcinoma (BCC) is a common skin cancer type and affected individuals are known to be at risk of developing multiple consecutive tumours. Research into BCC multiplicity has, thus far, been challenging, due to a lack of national registration. This registry-based cohort study aimed to analyse the occurrence of multiple BCCs in Sweden, and risk factors for subsequent primary BCCs. Data regarding all histopathologically verified, primary BCC tumours in Sweden from 2004 to 2017 was extracted from the Swedish BCC Registry. Risk of developing a subsequent BCC in relation to person-related factors was estimated with Cox regression analysis. Cumulative risk of BCC development after 1 or 3 earlier BCCs was estimated. In total, 39.9% of individuals with a registered BCC had at least 2 registered tumours. The risk of developing a subsequent BCC increased significantly in males, older age, and with residence in southern Sweden. The cumulative 5-year risk of developing an additional BCC after first diagnosis was approximately 30% in males and 27% in females and increased after multiple previous BCCs. This study showed the cumulative risk of a subsequent BCC to increase with a history of multiple BCCs, indicating the need for clinical surveillance in these individuals.
Downloads
References
Verkouteren JA, Ramdas KH, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017; 177: 359-372.
https://doi.org/10.1111/bjd.15321 DOI: https://doi.org/10.1111/bjd.15321
Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev 2015; 24: 141-149.
https://doi.org/10.1097/CEJ.0000000000000056 DOI: https://doi.org/10.1097/CEJ.0000000000000056
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-1080.
https://doi.org/10.1111/j.1365-2133.2012.10830.x DOI: https://doi.org/10.1111/j.1365-2133.2012.10830.x
de Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, et al. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012; 148: 347-354.
https://doi.org/10.1001/archdermatol.2011.2244 DOI: https://doi.org/10.1001/archdermatol.2011.2244
Kappelin J, Green AC, Ingvar A, Ahnlide I, Nielsen K. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study. Br J Dermatol 2022; 186: 963-969.
https://doi.org/10.1111/bjd.20964 DOI: https://doi.org/10.1111/bjd.20964
Flohil SC, Koljenovic S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011; 165: 874-881.
https://doi.org/10.1111/j.1365-2133.2011.10488.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10488.x
National Board of Health and Welfare. Basal cell carcinoma in Sweden 2004-2008. 2009.
R Core Development Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021.
Flohil SC, van der Leest RJ, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 2013; 49: 2365-2375.
https://doi.org/10.1016/j.ejca.2013.03.010 DOI: https://doi.org/10.1016/j.ejca.2013.03.010
Kiiski V, de Vries E, Flohil SC, Bijl MJ, Hofman A, Stricker BH, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010; 146: 848-855.
https://doi.org/10.1001/archdermatol.2010.155 DOI: https://doi.org/10.1001/archdermatol.2010.155
Kuo KY, Batra P, Cho HG, Li S, Chahal HS, Rieger KE, et al. Correlates of multiple basal cell carcinoma in a retrospective cohort study: sex, histologic subtypes, and anatomic distribution. J AM Acad Dermatol 2017; 77: 233-234 e232.
https://doi.org/10.1016/j.jaad.2017.02.047 DOI: https://doi.org/10.1016/j.jaad.2017.02.047
Flohil SC, Proby CM, Forrest AD, van Tiel S, Saksela O, Pitkanen S, et al. Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions. Br J Dermatol 2012; 167: 22-28.
https://doi.org/10.1111/j.1365-2133.2012.11083.x DOI: https://doi.org/10.1111/j.1365-2133.2012.11083.x
Backman E, Oxelblom M, Gillstedt M, Dahlén Gyllencreutz J, Paoli J. Basal cell carcinoma: epidemiological impact of clinical versus histopathological diagnosis. J Eur Acad Dermatol Venereol 2023; 37: 521-527.
https://doi.org/10.1111/jdv.18774 DOI: https://doi.org/10.1111/jdv.18774
Ciążyńska M, Pabianek M, Sławińska M, Reich A, Lewandowski B, Szczepaniak K, et al. Risk factors and clinicopathological features for developing a subsequent primary cutaneous squamous and basal cell carcinomas. Cancers (Basel) 2022; 14: 3069.
https://doi.org/10.3390/cancers14133069 DOI: https://doi.org/10.3390/cancers14133069
Bastiaens MT, Hoefnagel JJ, Bruijn JA, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998; 110: 880-884.
https://doi.org/10.1046/j.1523-1747.1998.00217.x DOI: https://doi.org/10.1046/j.1523-1747.1998.00217.x
Keim U, van der Pols JC, Williams GM, Green AC. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study. J Invest Dermatol 2015; 135: 728-733.
https://doi.org/10.1038/jid.2014.410 DOI: https://doi.org/10.1038/jid.2014.410
Kushnir-Grinbaum D, Krausz J, Rahal N, Apel-Sarid L, Ziv M. Risk of melanoma in patients with basal cell carcinoma: a population-based cohort study. Acta Derm Venereol 2023; 103: adv00841.
https://doi.org/10.2340/actadv.v103.4402 DOI: https://doi.org/10.2340/actadv.v103.4402
van Iersel CA, van de Velden HV, Kusters CD, Spauwen PH, Blokx WA, Kiemeney LA, et al. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005; 153: 1078-1080.
https://doi.org/10.1111/j.1365-2133.2005.06911.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06911.x
Pandeya N, Olsen CM, Whiteman DC. The incidence and multiplicity rates of keratinocyte cancers in Australia. Med J Aust 2017; 207: 339-343.
https://doi.org/10.5694/mja17.00284 DOI: https://doi.org/10.5694/mja17.00284
Sinikumpu SP, Jokelainen J, Keinänen-Kiukaanniemi S, Huilaja L. Skin cancers and their risk factors in older persons: a population-based study. BMC Geriatr 2022; 22: 269.
https://doi.org/10.1186/s12877-022-02964-1 DOI: https://doi.org/10.1186/s12877-022-02964-1
Venables ZC, Nijsten T, Wong KF, Autier P, Broggio J, Deas A, et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study. Br J Dermatol 2019; 181: 474-482.
https://doi.org/10.1111/bjd.17873 DOI: https://doi.org/10.1111/bjd.17873
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Johan Kappelin, Ingela Ahnlide, Åsa Ingvar, Kari Nielsen
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
